(Stroke. 1997;28:580-583.)
© 1997 American Heart Association, Inc.
Articles |
Perindopril Reduces Blood Pressure but Not Cerebral Blood Flow in Patients With Recent Cerebral Ischemic Stroke
From the Acute Stroke Unit, University Department of Medicine and Therapeutics, Western Infirmary, Glasgow, Scotland.
Correspondence to Dr A.G. Dyker, University Department of Medicine and Therapeutics, Western Infirmary, Glasgow G11 6NT, Scotland.
Background and Purpose The relationship between high blood pressure and the incidence of stroke is well established. Currently the effects of lowering blood pressure in patients with established cerebrovascular disease is undetermined, and there is continuing concern regarding the treatment of patients soon after a stroke event. Angiotensin-converting enzyme inhibitors maintain cerebral blood flow despite lowering blood pressure in patients with heart failure and otherwise uncomplicated hypertension. We tested the hypothesis that perindopril, an angiotensin-converting enzyme inhibitor with a gradual onset of action and a minimal first-dose hypotensive effect, lowers blood pressure without adversely affecting cerebral blood flow in patients 2 to 7 days after symptoms of cerebral infarction.
Methods Patients were randomized to receive 15 days of oral perindopril (4 mg) or placebo in a double-blind study. Blood pressure was monitored semiautomatically. Cerebral blood flow was calculated from internal carotid artery and vertebral Doppler ultrasound, supplemented by middle cerebral artery blood velocities.
Results Twenty-four patients completed the protocol; four additional patients were withdrawn for reasons unrelated to treatment. Patients on perindopril had a placebo-corrected reduction in blood pressure of 19/11 mm Hg. Blood pressure remained reduced after 2 weeks of treatment. In contrast, total cerebral blood flow was unaffected by perindopril. Neurological symptoms improved similarly in both groups.
Conclusions Perindopril was well tolerated and effectively reduced blood pressure without reducing carotid territory blood flow in patients with symptoms of recent cerebral ischemia.
Key Words: angiotensin-converting enzyme inhibitors • cerebral blood flow • Doppler • hypertension
This article has been cited by other articles:
 |
|
 |
|
  K. Fox Benefits of perindopril all along the cardiovascular continuum: the level of evidence Eur. Heart J. Suppl., September 1, 2008; 10(suppl_G): G4 - G12. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Zazulia, T. O. Videen, and W. J. Powers Symptomatic autoregulatory failure in acute ischemic stroke Neurology, January 30, 2007; 68(5): 389 - 390. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Willmot, A. Ghadami, B. Whysall, W. Clarke, J. Wardlaw, and P. M.W. Bath Transdermal Glyceryl Trinitrate Lowers Blood Pressure and Maintains Cerebral Blood Flow in Recent Stroke Hypertension, June 1, 2006; 47(6): 1209 - 1215. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Zuliani, A. Cherubini, S. Volpato, A. R. Atti, A. Ble, C. Vavalle, F. Di Todaro, C. Benedetti, C. Ruggiero, U. Senin, et al. Treatment With Angiotensin-Converting Enzyme Inhibitors Is Associated With a Reduction in Short-Term Mortality in Older Patients With Acute Ischemic Stroke J. Gerontol. A Biol. Sci. Med. Sci., April 1, 2005; 60(4): 463 - 465. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.A.L. Bain, M.R. Walters, K.R. Lees, and M.A. Lumsden The effect of HRT on cerebral haemodynamics and cerebral vasomotor reactivity in post-menopausal women Hum. Reprod., October 1, 2004; 19(10): 2411 - 2414. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Hatazawa, E. Shimosegawa, Y. Osaki, M. Ibaraki, N. Oku, S. Hasegawa, K. Nagata, Y. Hirata, and Y. Miura Long-Term Angiotensin-Converting Enzyme Inhibitor Perindopril Therapy Improves Cerebral Perfusion Reserve in Patients With Previous Minor Stroke Stroke, September 1, 2004; 35(9): 2117 - 2122. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Walters, S. Muir, I. Shah, and K. Lees Effect of Perindopril on Cerebral Vasomotor Reactivity in Patients With Lacunar Infarction Stroke, August 1, 2004; 35(8): 1899 - 1902. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. I. Sokol, E. L. Portnay, J. P. Curtis, M. A. Nelson, P. R. Hebert, J. F. Setaro, and J. M. Foody Modulation of the renin-angiotensin-aldosterone system for the secondary prevention of stroke Neurology, July 27, 2004; 63(2): 208 - 213. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Leonardi-Bee, P. M.W. Bath, S. J. Phillips, and P. A.G. Sandercock Blood Pressure and Clinical Outcomes in the International Stroke Trial Stroke, May 1, 2002; 33(5): 1315 - 1320. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Bath, G. Boysen, G. Donnan, M. Kaste, K. R Lees, T. Olsen, K. Overgaard, P. Sandercock, and N.-G. Wahlgren Hypertension in Acute Stroke: What to Do? Stroke, July 1, 2001; 32 (7): 1697 - 1698. [Full Text] [PDF]
|
|
|
|
 |
|
 J. M Saavedra, T. Ito, and Y. Nishimura Review: The role of angiotensin II AT1-receptors in the regulation of the cerebral blood flow and brain ischaemia Journal of Renin-Angiotensin-Aldosterone System, March 1, 2001; 2(1_suppl): S102 - S109. [PDF]
|
|
|
|
|
|
M. R. Walters, A. Bolster, A. G. Dyker, and K. R. Lees Effect of Perindopril on Cerebral and Renal Perfusion in Stroke Patients With Carotid Disease Stroke, February 1, 2001; 32(2): 473 - 478. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D Hill, P. A Barber, A. M Demchuk, A. M Buchan, P. Bath, F. Bath, P. Rashid, and C. Weaver Acute ischaemic stroke BMJ, July 29, 2000; 321(7256): 299a - 299. [Full Text]
|
|
|
|
|
|
S. L. Dawson, B. N. Manktelow, T. G. Robinson, R. B. Panerai, and J. F. Potter Which Parameters of Beat-to-Beat Blood Pressure and Variability Best Predict Early Outcome After Acute Ischemic Stroke? Stroke, February 1, 2000; 31(2): 463 - 468. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. D. Feldman, N. Campbell, P. Larochelle, P. Bolli, E. D. Burgess, S. G. Carruthers, J. S. Floras, R. B. Haynes, G. Honos, F. H.H. Leenen, et al. 1999 Canadian recommendations for the management of hypertension Can. Med. Assoc. J., December 14, 1999; 161(90120): S1 - 17. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G.F. Cleland, M. Tendera, J. Adamus, N. Freemantle, C. S. Gray, M. Lye, D. O'Mahony, L. Polonski, J. Taylor, and PEP investigators Perindopril for elderly people with chronic heart failure: the PEP-CHF study Eur J Heart Fail, August 31, 1999; 1(3): 211 - 217. [Abstract] [Full Text] [PDF]
|
|